SEARCH

SEARCH BY CITATION

REFERENCES

  • Akiskal HS. 2007. The emergence of the bipolar spectrum: validation along clinical-epidemiologic and familial-genetic lines. Psychopharmacol Bull 40:99115.
  • Arey RN, Enwright JF 3rd, Spencer SM, Falcon E, Ozburn AR, Ghose S, Tamminga C, McClung CA. 2013. An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors. Mol Psychiatry.
  • Ashkenazy-Frolinger T, Kronfeld-Schor N, Juetten J, Einat H. 2010. It is darkness and not light: Depression-like behaviors of diurnal unstriped Nile grass rats maintained under a short photoperiod schedule. J Neurosci Methods 186:165170.
  • Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, et al. 2012. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Mol Psychiatry 17:887905.
  • Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, Schmitt A, Schneider A, Cabral H, Cagsal-Getkin O, et al. 2013. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. PLoS ONE 8:e48814.
  • Barbier E, Wang JB. 2009. Anti-depressant and anxiolytic like behaviors in PKCI/HINT1 knockout mice associated with elevated plasma corticosterone level. BMC Neurosci 10:132.
  • Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197207.
  • Bertsch B, Ogden CA, Sidhu K, Le-Niculescu H, Kuczenski R, Niculescu AB. 2005. Convergent functional genomics: A Bayesian candidate gene identification approach for complex disorders. Methods 37:274279.
  • Bourin M, Chenu F, Hascoet M. 2009. Topiramate and phenytoin anti-immobility effect in the mice forced swimming test is reversed by veratrine: Implication for bipolar depression treatment. Behav Brain Res 205:421425.
  • Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, Sangar S, Li Y, Mu Y, Chen G, Yu D, et al. 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221225.
  • Dao DT, Mahon PB, Cai X, Kovacsics CE, Blackwell RA, Arad M, Shi J, Zandi PP, O'Donnell P, Knowles JA, et al. 2010. Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans. Biol Psychiatry 68:801810.
  • Derks EM, Vorstman JA, Ripke S, Kahn RS, Ophoff RA. 2012. Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: A polygenic risk score analysis. PLoS ONE 7:e37852.
  • Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:5774.
  • Engel SR, Creson TK, Hao Y, Shen Y, Maeng S, Nekrasova T, Landreth GE, Manji HK, Chen G. 2009. The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol Psychiatry 14:448461.
  • Fanous AH, Zhou B, Aggen SH, Bergen SE, Amdur RL, Duan J, Sanders AR, Shi J, Mowry BJ, Olincy A, et al. 2012. Genome-wide association study of clinical dimensions of schizophrenia: Polygenic effect on disorganized symptoms. Am J Psychiatry 169:13091317.
  • Ferreira MA, O'Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, et al. 2008. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:10561058.
  • Gould TD, O'Donnell KC, Picchini AM, Manji HK. 2007. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: A mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 32:13211333.
  • Gould TD, O'Donnell KC, Picchini AM, Dow ER, Chen G, Manji HK. 2008. Generation and behavioral characterization of beta-catenin forebrain-specific conditional knock-out mice. Behav Brain Res 189:117125.
  • Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E, Grozeva D, Kirov G, Holmans P, Moran JL, et al. 2012. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol Psychiatry
  • Herman L, Hougland T, El-Mallakh RS. 2007. Mimicking human bipolar ion dysregulation models mania in rats. Neurosci Biobehav Rev 31:874881.
  • Hunsberger JG, Machado-Vieira R, Austin DR, Zarate C, Chuang DM, Chen G, Reed JC, Manji HK. 2011. Bax inhibitor 1, a modulator of calcium homeostasis, confers affective resilience. Brain Res 1403:1927.
  • Johnson SA, Wang JF, Sun X, McEwen BS, Chattarji S, Young LT. 2009. Lithium treatment prevents stress-induced dendritic remodeling in the rodent amygdala. Neuroscience 163:3439.
  • Kakefuda K, Oyagi A, Ishisaka M, Tsuruma K, Shimazawa M, Yokota K, Shirai Y, Horie K, Saito N, Takeda J, et al. 2010. Diacylglycerol kinase beta knockout mice exhibit lithium-sensitive behavioral abnormalities. PLoS ONE 5:e13447.
  • Kasahara T, Kubota M, Miyauchi T, Noda Y, Mouri A, Nabeshima T, Kato T. 2006. Mice with neuron-specific accumulation of mitochondrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry 11:577593, 523.
  • Kato T, Ishiwata M, Yamada K, Kasahara T, Kakiuchi C, Iwamoto K, Kawamura K, Ishihara H, Oka Y. 2008. Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder. Neurosci Res 61:143158.
  • Keers R, Pedroso I, Breen G, Aitchison KJ, Nolan PM, Cichon S, Nothen MM, Rietschel M, Schalkwyk LC, Fernandes C. 2012. Reduced anxiety and depression-like behaviours in the circadian period mutant mouse after hours. PLoS ONE 7:e38263.
  • Kelly MP, Logue SF, Dwyer JM, Beyer CE, Majchrowski H, Cai Z, Liu Z, Adedoyin A, Rosenzweig-Lipson S, Comery TA. 2009. The supra-additive hyperactivity caused by an amphetamine–chlordiazepoxide mixture exhibits an inverted-U dose response: Negative implications for the use of a model in screening for mood stabilizers. Pharmacol Biochem Behav 92:649654.
  • Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, Gupta N, Sklar P, Sullivan PF, Moran JL, et al. 2012. Exome sequencing and the genetic basis of complex traits. Nat Genet 44:623630.
  • Kirshenbaum GS, Clapcote SJ, Petersen J, Vilsen B, Ralph MR, Roder JC. 2012. Genetic suppression of agrin reduces mania-like behavior in Na+, K+ -ATPase alpha3 mutant mice. Genes Brain Behav 11:436443.
  • Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS. 2010. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 107:26692674.
  • Kovacsics CE, Gould TD. 2010. Shock-induced aggression in mice is modified by lithium. Pharmacol Biochem Behav 94:380386.
  • Kubota M, Kasahara T, Iwamoto K, Komori A, Ishiwata M, Miyauchi T, Kato T. 2010. Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder. Int J Neuropsychopharmacol 114.
  • Kurian SM, Le-Niculescu H, Patel SD, Bertram D, Davis J, Dike C, Yehyawi N, Lysaker P, Dustin J, Caligiuri M, et al. 2011. Identification of blood biomarkers for psychosis using convergent functional genomics. Molecular psychiatry 16:3758.
  • Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T, Papolos DF, Stopkova P. 2007. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet Part B 144B:259265.
  • Le-Niculescu H, McFarland M, Ogden C, Balaraman Y, Patel S, Tan J, Rodd Z, Paulus M, Geyer M, Edenberg H, et al. 2008. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. Am J Med Genet Part B 147B:134166.
  • Le-Niculescu H, Patel SD, Bhat M, Kuczenski R, Faraone SV, Tsuang MT, McMahon FJ, Schork NJ, Nurnberger JI Jr, Niculescu AB 3rd. 2009a. Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet Part B 150B:155181.
  • Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, Tsuang MT, Salomon DR, Nurnberger JI Jr, Niculescu AB. 2009b. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 14:156174.
  • Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, Shekhar A, Schork N, Geyer MA, Niculescu AB. 2011. Convergent functional genomics of anxiety disorders: Translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry 1:e9.
  • Le-Niculescu H, Case NJ, Hulvershorn L, Patel SD, Bowker D, Gupta J, Bell R, Edenberg HJ, Tsuang MT, Kuczenski R, et al. 2011. Convergent functional genomic studies of omega-3 fatty acids in stress reactivity, bipolar disorder and alcoholism. Transl Psychiatry 1:e4.
  • Leussis MP, Berry-Scott EM, Saito M, Jhuang H, de Haan G, Alkan O, Luce CJ, Madison JM, Sklar P, Serre T, et al. 2012. The ANK3 bipolar disorder gene regulates psychiatric-related behaviors that are modulated by lithium and stress. Biol Psychiatry
  • Li N, He X, Qi X, Zhang Y, He S. 2010. The mood stabilizer lamotrigine produces antidepressant behavioral effects in rats: Role of brain-derived neurotrophic factor. J Psychopharmacol 24:17721778.
  • Lin M, Pedrosa E, Shah A, Hrabovsky A, Maqbool S, Zheng D, Lachman HM. 2011. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 6:e23356.
  • Liu Y, Blackwood DH, Caesar S, de Geus EJ, Farmer A, Ferreira MA, Ferrier IN, Fraser C, Gordon-Smith K, Green EK, et al. 2011. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol Psychiatry 16:24.
  • Macedo DS, de Lucena DF, Queiroz AI, Cordeiro RC, Araujo MM, Sousa FC, Vasconcelos SM, Hyphantis TN, Quevedo J, McIntyre RS, et al. 2013. Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: Relevance as an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 43C:230237.
  • Malkesman O, Weller A. 2009. Two different putative genetic animal models of childhood depression—A review. Prog Neurobiol 88:153169.
  • Malkesman O, Scattoni ML, Paredes D, Tragon T, Pearson B, Shaltiel G, Chen G, Crawley JN, Manji HK. 2010. The female urine sniffing test: A novel approach for assessing reward-seeking behavior in rodents. Biol Psychiatry 67:864871.
  • Marcheva B, Ramsey KM, Buhr ED, Kobayashi Y, Su H, Ko CH, Ivanova G, Omura C, Mo S, Vitaterna MH, et al. 2010. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466:627631.
  • McGrath CL, Glatt SJ, Sklar P, Le-Niculescu H, Kuczenski R, Doyle AE, Biederman J, Mick E, Faraone SV, Niculescu AB, et al. 2009. Evidence for genetic association of RORB with bipolar disorder. BMC Psychiatry 9:70.
  • Miller BH, Zeier Z, Xi L, Lanz TA, Deng S, Strathmann J, Willoughby D, Kenny PJ, Elsworth JD, Lawrence MS, et al. 2012. MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A 109:31253130.
  • Mingmalairak S, Tohda M, Murakami Y, Matsumoto K. 2010. Possible involvement of signal transducers and activators of transcription 3 system on depression in the model mice brain. Biol Pharm Bull 33:636640.
  • Mukherjee S, Coque L, Cao JL, Kumar J, Chakravarty S, Asaithamby A, Graham A, Gordon E, Enwright JF III, Dileone RJ, et al. 2010. Knockdown of clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biol Psychiatry 68:503511.
  • Niculescu AB III. 2006. Polypharmacy in oligopopulations: What psychiatric genetics can teach biological psychiatry. Psychiatr Genet 16:241244.
  • Niculescu AB, Le-Niculescu H. 2010a. Convergent functional genomics: What we have learned and can learn about genes, pathways, and mechanisms. Neuropsychopharmacology 35:355356.
  • Niculescu AB, Le-Niculescu H. 2010b. The P-value illusion: How to improve (psychiatric) genetic studies. Am J Med Genet Part B 153B:847849.
  • Niculescu AB III, Segal DS, Kuczenski R, Barrett T, Hauger RL, Kelsoe JR. 2000. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach. Physiol Genomics 4:8391.
  • Niculescu AB, Lulow LL, Ogden CA, Le-Niculescu H, Salomon DR, Schork NJ, Caligiuri MP, Lohr JB. 2006. PhenoChipping of psychotic disorders: A novel approach for deconstructing and quantitating psychiatric phenotypes. Am J Med Genet Part B 141B:653662.
  • Niculescu AB III, Schork NJ, Salomon DR. 2010. Mindscape: A convergent perspective on life, mind, consciousness and happiness. J Affect Disord 123:18.
  • Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NG, Kano S, Ozaki N, Nabeshima T, et al. 2013. Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339:335339.
  • Ogden CA, Rich ME, Schork NJ, Paulus MP, Geyer MA, Lohr JB, Kuczenski R, Niculescu AB. 2004. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: An expanded convergent functional genomics approach. Mol Psychiatry 9:10071029.
  • Patel SD, Le-Niculescu H, Koller DL, Green SD, Lahiri DK, McMahon FJ, Nurnberger JI Jr, Niculescu AB III. 2010. Coming to grips with complex disorders: Genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet Part B 153B:850877.
  • Rodd ZA, Bertsch BA, Strother WN, Le-Niculescu H, Balaraman Y, Hayden E, Jerome RE, Lumeng L, Nurnberger JI Jr, Edenberg HJ, et al. 2007. Candidate genes, pathways and mechanisms for alcoholism: An expanded convergent functional genomics approach. Pharmacogenomics J 7:222256.
  • Roybal K, Theobold D, Graham A, Dinieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, et al. 2007. From the cover: Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci U S A 104:64066411.
  • Saul MC, Gessay GM, Gammie SC. 2012. A new mouse model for mania shares genetic correlates with human bipolar disorder. PLoS ONE 7:e38128.
  • Schulze TG, Detera-Wadleigh SD, Akula N, Gupta A, Kassem L, Steele J, Pearl J, Strohmaier J, Breuer R, Schwarz M, et al. 2009. Two variants in Ankyrin 3 (ANK3) are independent genetic risk factors for bipolar disorder. Mol Psychiatry 14:487491.
  • Scott LJ, Muglia P, Kong XQ, Guan W, Flickinger M, Upmanyu R, Tozzi F, Li JZ, Burmeister M, Absher D, et al. 2009. Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A 106:75017506.
  • Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T, Rogawski M, Gasior M, Luckenbaugh D, Chen G, et al. 2008. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 13:858872.
  • Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, et al. 2008. Whole-genome association study of bipolar disorder. Molecular Psychiatry 13:558569.
  • Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, et al. 2009. Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14:755763.
  • Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, Santangelo S, Sullivan PF. 2013. Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381:13711379.
  • Soronen P, Ollila HM, Antila M, Silander K, Palo OM, Kieseppa T, Lonnqvist J, Peltonen L, Tuulio-Henriksson A, Partonen T, et al. 2010. Replication of GWAS of bipolar disorder: association of SNPs near CDH7 with bipolar disorder and visual processing. Mol Psychiatry 15:46.
  • Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietilainen OP, Lin K, Papiol S, Huttenlocher J, et al. 2012. Common variant at 16p11.2 conferring risk of psychosis. Mol Psychiatry
  • Tajinda K, Ishizuka K, Colantuoni C, Morita M, Winicki J, Le C, Lin S, Schretlen D, Sawa A, Cascella NG. 2010. Neuronal biomarkers from patients with mental illnesses: A novel method through nasal biopsy combined with laser-captured microdissection. Mol Psychiatry 15:231232.
  • Taniguchi S, Nakazawa T, Tanimura A, Kiyama Y, Tezuka T, Watabe AM, Katayama N, Yokoyama K, Inoue T, Izumi-Nakaseko H, et al. 2009. Involvement of NMDAR2A tyrosine phosphorylation in depression-related behaviour. EMBO J 28:37173729.
  • van Enkhuizen J, Geyer MA, Kooistra K, Young JW. 2012. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. Int J Neuropsychopharmacol 111.
  • Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661678.
  • Whalley HC, Sprooten E, Hackett S, Hall L, Blackwood DH, Glahn DC, Bastin M, Hall J, Lawrie SM, Sussmann JE, et al. 2013. Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol Psychiatry.
  • Will CC, Aird F, Redei EE. 2003. Selectively bred Wistar–Kyoto rats: An animal model of depression and hyper-responsiveness to antidepressants. Mol Psychiatry 8:925932.
  • Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, Carroll L, Georgieva L, Williams NM, Morris DW, Quinn EM, et al. 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry
  • Yang S, Van Dongen HP, Wang K, Berrettini W, Bucan M. 2009. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 14:143155.
  • Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. 2010b. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav 96:715.
  • Young JW, Goey AK, Minassian A, Perry W, Paulus MP, Geyer MA. 2010a. GBR 1290 9 administration as a mouse model of bipolar disorder mania: Mimicking quantitative assessment of manic behavior. Psychopharmacology 208:443454.
  • Zhang D, Cheng L, Qian Y, Alliey-Rodriguez N, Kelsoe JR, Greenwood T, Nievergelt C, Barrett TB, McKinney R, Schork N, et al. 2009. Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14:376380.